Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeriy Parfenov

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Neurologist|June 16, 2015
Management of Fulminant Multiple Sclerosis With Rituximab: A Case ReportValeriy Parfenov, Renaud Du Pasquier, Myriam Schluep
Journal of the Neurological Sciences|July 10, 2013
Assessing risks of multiple sclerosis therapiesValeriy Parfenov, Myriam Schluep, Renaud Du Pasquier
Cellular and Molecular Life Sciences : CMLS|April 25, 2012
Type I IFN-mediated regulation of IL-1 production in inflammatory disordersKristina Ludigs, Valeriy Parfenov, Renaud A Du Pasquier, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Neurologist|June 16, 2015
Management of Fulminant Multiple Sclerosis With Rituximab: A Case ReportValeriy Parfenov, Renaud Du Pasquier, Myriam Schluep
Journal of the Neurological Sciences|July 10, 2013
Assessing risks of multiple sclerosis therapiesValeriy Parfenov, Myriam Schluep, Renaud Du Pasquier
Cellular and Molecular Life Sciences : CMLS|April 25, 2012
Type I IFN-mediated regulation of IL-1 production in inflammatory disordersKristina Ludigs, Valeriy Parfenov, Renaud A Du Pasquier, et al.
Pageof 1